Reading CLB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CLB free→Reading CLB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CLB free→NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-06-16
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral, and earnings quality is fragile, reported profits aren't backed by cash. Management's recent track record has been steady, but risk is elevated, and the sector backdrop is a headwind. Peer multiples imply a price about 10% above where it trades (it looks cheap on this basis); the read is fair, but weakening. If CLB cuts guidance on the next call, that's a meaningful negative. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $12.17. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $13 CLB trades at 19× p/e, below its 21× p/e peer median. Our $14 fair value sits above the price; high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 8% below a flat-multiple fair value; not enough history to forecast a comparison. This describes what's priced in, not a forecast of the move.
Only weak execution quality, a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Energy names rated neutral grew net income 53% of the time over the next year (vs 60% for the rest of the cohort, n=1255).
Over the trailing year it converted 1.18x of net income into operating cash flow. Historically, Energy names rated fragile grew net income 38% of the time over the next year (vs 44% for the rest of the cohort, n=602).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, Fed net liquidity, real (inflation-adjusted) rates.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.14 → $0.09 (-37.9% / 30d). 1 raised, 1 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d. 33% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 3 guided quarters · 5.0% avg surprise
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$196.
How much price usually moves either way.
On a bad day, this stock has moved -$483.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,810.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Lower revenue guidance shows ongoing problems from conflicts and disruptions.
Confirms:If Q2 2026 revenue is below $119 million, it shows ongoing problems.
Disproves:If Q2 2026 revenue is above $123 million, it means client activity is improving.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CLB yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On April 29, 2026, Core Laboratories Inc. issued a press release announcing its financial results for the first quarter of 2026.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Oil & Gas Equipment & Services.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CLB Core Laboratories | Typical Show detailsSector percentile: 35 of 100 | fair | elevated |
SLB Schlumberger | Typical Show detailsSector percentile: 61 of 100 | fair | moderate |
BKR Baker Hughes | Above typical Show detailsSector percentile: 74 of 100 | full | moderate |
HAL Halliburton | Above typical Show detailsSector percentile: 80 of 100 | fair | moderate |
FTI TechnipFMC | Above typical Show detailsSector percentile: 82 of 100 | full | moderate |
3 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Energy names rated stable grew net income 53% of the time over the next year (vs 45% for the rest of the cohort, n=249).
Not investment advice. As of 2026-06-16.
via XLE
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue efforts to enhance operational efficiency to improve financial performance.
Continue to provide a quarterly cash dividend to shareholders.
Project revenue growth with guidance for upcoming quarters.
Regulation FD Disclosure. On April 29, 2026, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on May 11, 2026 and payable June 1, 2026. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange…
Results of Operations and Financial Condition. The Original Form 8-K included, as Exhibit 99.1 thereto, a copy of the Company’s press release that was issued on February 4, 2026 announcing the financial results of the Company for the quarter and year ended December 31, 2025 (the “Earnings Release”). Subsequent to the Company’s fourth quarter earnings call on February 5, 2026 and during the preparation of its audited consolidated financial statements to be included in the Company’s Annual Repo…
Results of Operations and Financial Condition. On February 4, 2026, Core Laboratories Inc. issued a press release announcing its financial results for the fourth quarter of 2025 and year ending December 31, 2025.
Regulation FD Disclosure. On February 4, 2026, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on February 16, 2026 and payable March 9, 2026. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “E…